Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 55,921 | 59,675 | 75,781 | 101,236 | 26,752 |
| Receivables | 13,237 | 6,335 | 6,514 | 7,108 | 3,470 |
| Inventories | 81,536 | 69,753 | 56,001 | 52,289 | 53,065 |
| TOTAL | $153,741 | $139,549 | $142,990 | $165,488 | $85,820 |
| Non-Current Assets | |||||
| PPE Net | 41,593 | 39,623 | 37,373 | 35,061 | 31,741 |
| Intangibles | 5,974 | 6,153 | 6,331 | 6,510 | 6,689 |
| Other Non-Current Assets | 6,366 | 4,653 | 4,847 | 3,465 | 2,840 |
| TOTAL | $53,933 | $50,428 | $48,552 | $45,036 | $41,270 |
| Total Assets | $207,673 | $189,976 | $191,542 | $210,524 | $127,091 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 229 |
| Accounts payable and accrued liabilities | 11,074 | 7,980 | 6,910 | 9,152 | 9,175 |
| Accrued Expenses | 8,365 | 8,075 | 5,617 | 4,419 | 4,481 |
| TOTAL | $19,947 | $16,474 | $12,880 | $13,908 | $14,028 |
| Non-Current Liabilities | |||||
| Long Term Debt | 92,969 | 97,044 | 96,574 | 96,129 | 83,199 |
| Deferred Revenues | 143 | 143 | 143 | 143 | 143 |
| Other Non-Current Liabilities | 55 | 68 | 81 | 94 | 107 |
| TOTAL | $99,477 | $102,127 | $101,782 | $100,280 | $86,870 |
| Total Liabilities | $119,424 | $118,600 | $114,662 | $114,188 | $100,898 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 121,275 | 94,548 | 86,350 | 86,345 | 86,345 |
| Common Shares | 11 | 9 | 9 | 9 | 6 |
| Retained earnings | -340,465 | -321,057 | -304,140 | -283,962 | -264,717 |
| TOTAL | $88,249 | $71,376 | $76,880 | $96,336 | $26,193 |
| Total Liabilities And Equity | $207,673 | $189,976 | $191,542 | $210,524 | $127,091 |